Par C209 Pill - brown & yellow capsule/oblong
Pill with imprint Par C209 is Brown & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 45 mg. It is supplied by Par Pharmaceutical Companies, Inc.
Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Par C209
Fenofibric Acid Delayed-Release
- Imprint
- Par C209
- Strength
- 45 mg
- Color
- Brown & Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Companies, Inc.
- National Drug Code (NDC)
- 10370-0209 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
stearic acid,
magnesium silicate,
triethyl citrate,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
D&C Yellow No. 10,
ferrosoferric oxide,
propylene glycol,
shellac,
FD&C Yellow No. 6,
gelatin,
ferric oxide red,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about fenofibric acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
